Background: Low circulating levels of sex hormone-binding globulin (SHBG) have been shown to be a direct and strong risk factor for type 2 diabetes, cardiovascular diseases, and hormone-dependent cancers, although the relationship between various aspects of dietary carbohydrates and SHBG levels remains unexplored in population studies. Methods: Among postmenopausal women with available SHBG measurements at baseline (n = 11 159) in the Women's Health Initiative, a comprehensive assessment was conducted of total dietary carbohydrates, glycemic load (GL), glycemic index (GI), fiber, sugar, and various carbohydrate-abundant foods in relation to circulating SHBG levels using multiple linear regressions adjusting for potential covariates. Linear trend was tested across quartiles of dietary variables. Benjamini and Hochberg's procedure was used to calculate the false discovery rate for multiple comparisons. Results: Higher dietary GL and GI (both based on total and available carbohydrates) and a higher intake of sugar and sugar-sweetened beverages were associated with lower circulating SHBG concentrations (all P trend < 0.05; Q-values = 0.04,0.01, 0.07, 0.10, 0.01, and <0.0001, respectively). In contrast, women with a greater intake of dietary fiber tended to have elevated SHBG levels (P trend = 0.01, Q-value = 0.04). There was no significant association between total carbohydrates or other carbohydrate-abundant foods and SHBG concentrations. Conclusions: The findings suggest that low GL or GI diets with low sugar and high fiber content may be associated with higher serum SHBG concentrations among postmenopausal women. Future studies investigating whether lower GL or GI diets increase SHBG concentrations are warranted.
Introduction
Sex hormone-binding globulin (SHBG) is a serum protein synthesized by the liver that binds to both androgens and estrogens, with higher affinity for androgens.
1,2 Sex hormone-binding globulin was originally thought to primarily regulate the amount of sex hormones bioavailable to cells; however, recent epidemiological studies consistently show that low SHBG concentrations are strongly associated with the development of insulin resistance, type 2 diabetes (T2D), cardiovascular diseases (CVD), hormone-dependent cancers, and hip fractures, either indirectly by modulating the biologic effects of testosterone or directly through the SHBG receptor. 1, [3] [4] [5] [6] [7] [8] [9] [10] Mendelian randomization analyses using single nucleotide polymorphisms within or near the SHBG gene as instrumental variables for blood SHBG concentrations also provide supporting evidence for the causal relationship between SHBG and the risk of T2D. 3, 11 Given the role SHBG may play in the etiologies of T2D, CVD, and hormone-dependent cancers, investigating the determinants of blood SHBG concentrations is of great importance. In addition to several common variants identified within or near the SHBG gene, 3, 11 lifestyle factors, especially dietary factors, may have a direct effect on circulating concentrations of free endogenous sex hormones through regulation of SHBG concentrations. 12 Physical activity, regular coffee consumption, and weight loss by exercise and/or caloric restriction have been found to increase SHBG concentrations in postmenopausal women. 13, 14 Emerging evidence also shows that different types of dietary carbohydrates may have heterogeneous associations with SHBG concentrations. 2, [15] [16] [17] [18] In a dietary intervention study, lower serum SHBG concentrations were observed among participants on a conventional highglycemic load diet, whereas SHBG concentrations increased among those on a high-protein, low-glycemic load diet. 15 Fiber intake was found to be positively correlated with SHBG concentrations in a previous study in men, 16 but another study failed to observe a similar correlation in postmenopausal women. 17 Moreover, although an inverse association between monosaccharides and SHBG production was reported previously in transgenic mice and hepatic cell models, 18 a more recent study found that sweets intake may be positively correlated with SHBG concentrations, although the result was not significant. 2 Increasing attention has been attracted to the effect of dietary factors on circulating SHBG concentrations. Nevertheless, studies examining the effect of the quality and quantity of dietary carbohydrates on SHBG are still scarce and inconclusive, and very few have investigated foods that are abundant in carbohydrates. Therefore, we conducted a comprehensive examination of the relationships between various measures of dietary carbohydrates and concentrations of circulating SHBG among a subsample from the large-scale national Women's Health Initiative (WHI) study. 19 
Methods

Study subjects
The WHI is a long-term national health study focused on strategies for preventing heart diseases, breast and colorectal cancer, and osteoporotic fractures in postmenopausal women. The original WHI study included 161 808 postmenopausal women enrolled between 1993 and 1998 in two major parts, a partial factorial randomized clinical trial (CT) and an observational study (OS); both were conducted at 40 clinical centers nationwide in the US. The CT enrolled 68 132 postmenopausal women aged between 50 and 79 years into trials testing three prevention strategies; the OS examined the relationship between lifestyle, environmental, medical and molecular risk factors, and specific measures of health or disease outcomes. This component involved tracking the medical history and health habits of 93 676 women not participating in the CT. 19 The present analysis included an initial total of 13 955 unique participants from either the WHI-CT or WHI-OS whose blood samples from baseline had been measured for serum SHBG in the following ancillary studies: AS90 (400 hip fracture cases, 400 controls), were excluded if they had implausible total energy intake (<600 or >5000 kcal/day) as determined by the food frequency questionnaire (n = 711 excluded), selfreported diabetes at baseline (n = 1072 further excluded), or if they had missing information for important covariates, such as age (no missing), race/ethnicity (n = 27), body mass index (n = 74), smoking status (n = 170), physical activity (n = 768), and hormone therapy use (n = 6); because there was overlap for these exclusion criteria, this step excluded 1013 participants. After applying the above exclusion criteria, participants had complete information in dietary measurements.
Measurement of serum SHBG concentrations
For each study participant, blood was collected at the baseline visit after at least a 12-h fast and then stored between −80 C and −70 C. Samples used for the hormone measurements were taken from these baseline specimens. Serum SHBG concentrations were measured using an electrochemiluminescence immunoassay (ECL) in AS238, a solid-phase, two-site chemiluminescent immunoassay (solid-phase, two-site CIA) in AS90, AS110, AS167, BA7, BA9, BA21, W9, W10, and W18, or an immunoradiometric assay (IRMA) in W5. The interassay coefficients of variation ranged between 3.7% and 17.7%. 2 
Dietary measurements
The methods of data collection and validation have been reported previously. 19, 22 At baseline, participants completed a 122-item standardized food frequency questionnaire (FFQ) developed for the WHI to estimate average daily dietary intake over the previous 3 months. 23 The FFQ was based on instruments used in the WHI feasibility studies and the original National Cancer Institute/ Block FFQ. [24] [25] [26] The dietary database, linked to the University of Minnesota Nutrition Coordinating Center Nutrition Data System for Research (Nutrition Coordinating Center, Minneapolis, MN, USA), is based on the US Department of Agriculture standard reference releases and manufacturer information. 27 Detailed descriptions of the methods used to calculate glycemic index (GI) and glycemic load (GL) values can be found elsewhere. 28 In summary, GI values based on food consumption or expert judgment were assigned to each food item that contained at least 5 g carbohydrates, and then for each FFQ line item GL values were calculated by multiplying GI by intake frequencies and portion sizes. Both total carbohydrates and available carbohydrates (total carbohydrates minus total fiber) were used to calculate GI and GL values. In addition, the dietary intake of total carbohydrates, total sugar, and total fiber was included in the analyses in separate models.
As a secondary analysis, the associations of different carbohydrate-abundant food items (daily servings of white bread, dark bread, rice, grains and noodles, potato, cereal, fruits, beans, sugar-sweetened beverages, pasta, and whole grains) with serum SHBG concentrations were also examined. The potato variable included French fries, potato salad, sweet potatoes, yams, and other potato, cassava, and yucca. The cereal variable included cold and cooked cereals. The beans variable included green or string beans, English peas, refried beans, all other beans, and bean soup. The sugarsweetened beverage variable included regular soft drinks (not diet), orange or grapefruit juice, other fruit juice, and fruit drinks. The pasta variable included macaroni and cheese, lasagna, or noodles with a cream sauce, spaghetti with meat sauce, and spaghetti with tomato sauce. All other variables were precalculated by the WHI. This FFQ has demonstrated reasonably good validity as a measurement of dietary intake compared with 24-h dietary recalls and food records. 23 
Statistical analysis
Baseline characteristics were summarized according to SHBG quartiles. Continuous variables are presented as the mean AE SD, whereas categorical variables are presented as percentages. The statistical significance of differences among SHBG quartiles was tested by analysis of variance (ANOVA) for continuous variables and by Chi-squared test for categorical variables. Individuallevel data from different ancillary studies were pooled and analyzed to assess the associations between measures of carbohydrate intake and ln-transformed SHBG concentrations using linear multivariable models. Dietary carbohydrate intake was analyzed in quartiles. We adjusted for potential confounding factors, including total energy intake, total carbohydrate intake (except when total carbohydrate intake was the exposure of interest), ancillary study indicators, case/control status in each ancillary study, age (continuous), ethnicity, BMI (continuous), cigarette smoking (never, past, or current), alcohol consumption (continuous), physical activity (metabolic equivalent of tasks per week, continuous), and hormone therapy use (never, past, or current user of unopposed estrogen and/or estrogen plus progesterone). From this model, we calculated the adjusted geometric mean of SHBG concentrations for each quartile of the carbohydrate of interest by exponentiating the estimated mean ln SHBG concentrations evaluated at the mean of each continuous variable and averaged over the groups of each categorical variable in the model. A linear trend analysis was also performed for each measure of carbohydrate by assigning the median of each quartile to each observation and using the resulting continuous variable as the independent variable in the model. In order to address the multiple testing issue, Benjamini and Hochberg's procedure for controlling the false discovery rate (FDR) was performed with the results of the trend analysis. 29 Measures of carbohydrate intake with a Q-value below 0.05 were considered statistically significant, which corresponded to less than one false positive result per 20 comparisons.
Sensitivity analyses were performed by: (i) restricting to only controls of each ancillary study; (ii) using linear mixed-effects models to pool the estimates from each ancillary study; (iii) additionally adjusting for dietary total protein, fruit and vegetable intake, and baseline history of CVD and cancer; and (iv) restricting to studies that measured SHBG using solid-phase, two-site CIA (nine of 11 studies). Furthermore, because SHBG concentrations have previously been inversely linked to the risk of T2D, 1, 3, 5 we hypothesized that dietary carbohydrates may affect the risk of T2D by affecting serum SHBG concentrations. Thus, we performed exploratory mediation analyses within the T2D case-control study in our sample (AS238; n = 1586 after applying exclusion criteria) with quartiles of dietary carbohydrate measures as the exposure (contrasting the highest and lowest quartiles), SHBG concentrations as the mediator, and case/control status as the outcome. [30] [31] [32] The average causal mediation effects, average direct effects, the proportion mediated, and their respective confidence intervals (CIs) were quantified. All statistical analyses were conducted using R version 3.3.1 (R Foundation for Statistical Computing, Vienna, Austria).
Results
A total of 11 159 postmenopausal women was included in the present analysis, with a median (interquartile range) serum SHBG concentration of 47.3 nmol/L (33.0-68.8 nmol/L). This group of participants was, on average, 65.3 AE 7.5 years old, had an average BMI of 28.6 AE 6.1 kg/m 2 , an average total energy intake of 1618 AE 661 kcal/day, and an average total carbohydrate intake of 201 AE 81 g/day. Sixty-eight percent of these women were White and 8.6% were smokers at study baseline. When comparing women across SHBG quartiles, those within higher SHBG quartiles tended to be older, were less likely to be White and more likely to be black or Asian, had lower BMI, and were more likely to be current smokers. Women with higher concentrations of serum SHBG also had a lower intake of total energy, total carbohydrates, protein, fat, sugar, GL, GI, and fruits and vegetables, although they had a similar intake of fiber compared with women with lower serum SHBG concentrations (Table 1) . Because the original continuous SHBG variable was skewed to the right, we performed natural logarithm transformation and used the ln-transformed SHBG variable as the dependent variable in the subsequent linear regression analyses. After adjusting for total energy intake, total carbohydrates (except when total carbohydrates was the exposure of interest), age, race, BMI, smoking status, physical activity, alcohol intake, hormone therapy use, ancillary study indicator, and case/ control status in each ancillary study, higher dietary GL based on both total carbohydrates and available carbohydrates was significantly associated with lower concentrations of serum SHBG (P trend = 0.01 and 0.002; Q-value = 0.04 and 0.01, respectively). Women within the lowest quartile of dietary GL based on available carbohydrates had an adjusted average SHBG of 56.7 nmol/L (95% CI 54.6, 58.9 nmol/L), whereas women within the highest quartile of dietary GL had an adjusted average SHBG of 52.6 nmol/L (95% CI 50.5, 54.7 nmol/L), and results were very similar for GL based on total carbohydrates. Similar trends were observed for dietary GI based on total and available carbohydrates (P trend = 0.02 and 0.04; Q-value = 0.07 and 0.10, respectively) and dietary sugar intake (P trend < 0.001; Q-value = 0.01), for which the lowest intake quartile had an average SHBG concentration of 56.2 nmol/L (95% CI 54.3, 58.1 nmol/L), whereas the highest intake quartile had an average of 52.1 nmol/L (95% CI 50.2, 54.1 nmol/L). In addition, a positive trend was found for fiber, whereby higher fiber intake was associated with higher SHBG concentrations (P trend = 0.01; Q-value = 0.04). No significant findings were observed for total carbohydrate intake ( Table 2) .
For analyses regarding carbohydrate-abundant food items, a significant inverse relationship was found between quartiles of sugar-sweetened beverages and circulating SHBG concentrations (P trend < 0.001; Qvalue < 0.001). The lowest intake quartile corresponded to an adjusted average SHBG concentration of 56.7 nmol/L (95% CI 55.0, 58.6 nmol/L), whereas the highest intake quartile corresponded to an average of 52.7 nmol/L (95% CI 51.1, 54.4 nmol/L). Interestingly, we also observed borderline inverse associations for potato intake (P trend = 0.07;Q-value = 0.16) and beans intake (P trend = 0.10; Q-value = 0.19). Other food items were not significantly associated with circulating SHBG concentrations (Table 3) .
When restricting analyses to just controls from ancillary studies, this subgroup included 5457 participants. Without correction for multiple comparisons, results were similar to those obtained from the primary analyses in the whole group (Tables 4-5). Dietary GL based on total and available carbohydrates, fiber, sugar, and sugar-sweetened beverages remained significantly associated with SHBG concentrations after the FDR procedure, and the effect sizes were also similar. The discrepancy was that the P-values for trend for dietary GI based on total and available carbohydrates were significant before and after the FDR procedure in the controls, whereas in the whole sample they were only significant before multiple testing correction. From the second sensitivity analyses we performed, the linear mixed-effects models where ancillary study indicators were treated as random effects yielded very similar results to the primary analyses (data not shown). In the third sensitivity analysis, when additionally adjusting for dietary total protein, fruit and vegetable intake, and baseline history of CVD and cancer, the results were virtually the same with those from the primary analysis (see Table S1 ). From the fourth sensitivity analysis, which was restricted to studies that measured SHBG using solid-phase, two-site CIA (9 of 11 studies), the estimated adjusted means of SHBG concentrations were overall lower than what we estimated in the original analytic sample, but the results regarding the trends across quartiles of dietary intake and their significance were similar to the results of the primary analysis (Table S2 ). The exploratory mediation analyses did not find significant average causal mediation effects or average direct effects, possibly due to the fact that one single case-control study was not powered enough to detect significant mediation effects (Table S3) .
Discussion
In the present cross-sectional analysis of 11 159 nondiabetic postmenopausal women enrolled in the WHI, positive associations with SHBG concentrations were observed for total dietary fiber intake. Total dietary sugar intake and dietary GL based on total and available carbohydrates were observed to be significantly associated with reduced serum concentrations of SHBG, before and after correction for multiple comparisons. Dietary GI based on total and available carbohydrates was also associated with lower levels of SHBG before multiple *Adjusted mean values were computed by exponentiating the least squares means of estimated log-transformed sex hormone-binding globulin (SHBG) concentrations from models including the exposure of interest, total carbohydrates (CHO; except when total CHO was the exposure of interest), total energy intake, age, race, body mass index, smoking status, physical activity, alcohol intake, hormone therapy use, ancillary study indicator, and case-control status in each ancillary study. A linear mixed model with ancillary study indicator as the random effect yielded very similar results. CI, confidence interval; GI, glycemic index; GL, glycemic load. testing correction. In addition, a significant association between sugar-sweetened beverages and decreased concentrations of serum SHBG was demonstrated based on analyses regarding carbohydrate-abundant food items, corroborating our results for total sugar intake.
Our finding of an inverse relationship between dietary GL based on total and available carbohydrates and serum SHBG concentrations was consistent with results from a previous dietary intervention trial where SHBG was considerably lowered after a 12-week high-GL diet compared with the baseline, and significantly decreased compared with those on a low-GL diet, 15 although another study contrasting low-GI and high-GI diets did not find significant differences in SHBG after an 8-week intervention. 33 This somewhat contradicted the fact that in the present analysis dietary GI based on total or available carbohydrates was significantly associated with SHBG concentrations, although only before correction for multiple comparisons. Mechanistically, it has been suggested that a high-GL or -GI diet induces greater insulin production, and insulin could act as an inhibitor of hepatic synthesis of SHBG. 18, [34] [35] [36] Dietary sugar, which is usually high in GI and GL, was found to be significantly and inversely associated with serum SHBG. This result is in line with biological evidence from human SHBG-transgenic mice and human hepatic cells, where glucose and fructose reduced human SHBG production by hepatocytes via the downregulation of hepatocyte nuclear factor-4α, which was independent of the actions of insulin. 18 Sugar also likely contributed to the relationship between dietary GL or GI and SHBG concentrations. The null relationship we observed between total carbohydrate intake and SHBG was consistent with observations from another study. 16 Collectively, these results suggested that the quality of dietary carbohydrates may be of greater importance than quantity in affecting circulating SHBG levels, given that our analyses with regard to GL and GI were adjusted for the total amount of dietary carbohydrates.
Dietary fiber, which did not contribute to GL or GI based on available carbohydrates, was positively associated with serum SHBG in the present analysis. Previous findings from the WHI Dietary Modification trial associated a low-fat dietary pattern with significant reduction in SHBG after 1 year of intervention, which was thought to be contributed, in part, by the concurrent increase in fiber intake as well as weight loss. 37 Even though an early study found no correlation between dietary fiber and SHBG, 17 a more recent investigation with regression modeling did reveal significant positive relationships between the two, accounting for age, BMI, and other covariates. 16 The biomarker of lignan intake was also found to be positively related to SHBG levels, despite the null association between dietary fiber and SHBG in the same study. 38 The mechanism by which fiber intake may be a controlling factor of SHBG is not yet well understood, but it is possible that it acts by modulating glucagon-like peptide-1 and insulin secretion. 39 We also systematically examined the primary carbohydrate-abundant food items that may be responsible for the effects of diet on SHBG concentrations in these data. A significant inverse relationship between sugar-sweetened beverages and circulating SHBG concentrations was discovered, and this mirrored our findings in the relationship between total sugar intake and SHBG concentrations. The significant inverse associations between total sugar intake, sugar-sweetened beverage intakes, and plasma SHBG concentrations illustrate the detrimental effects of excessive sugar consumption, which indicates that cutting down sugar intake may be an important intervention to increase SHBG concentrations. We also identified two food categories, namely potatoes and beans, which were borderline significantly inversely associated with SHBG concentrations, although there was a complete null association after correction for multiple comparisons or in analysis of controls only. Physiological studies show that most potatoes have a high GI, regardless of cooking method, which, over the long term, may increase the risk of obesity and chronic diseases such as T2D and CVD. 40 The cross-sectional nature of the present investigation raises concern over the temporality of the associations we observed. The WHI FFQ inquired about dietary intake during the 3-month period prior to study baseline, whereas the blood samples in which SHBG was measured were taken at baseline. Thus, the temporality between dietary carbohydrate intake and serum SHBG concentrations can be established to a certain extent. Another limitation of the present study is that measurements of SHBG from different ancillary studies of the WHI were included in order to boost the power of the study to detect the associations, especially with the moderately large number of testings in the present analysis. Heterogeneity among these studies in measuring serum SHBG, as well as different criteria for choosing study participants, may introduce bias into our results. We attempted to address this by including both the indicators of ancillary studies and indicators of case or control status in each ancillary study in our statistical modeling. We also restricted the analytic sample to participants from the 9 studies that used the same method of measuring SHBG. To evaluate the extent of bias, we also performed sensitivity analyses in controls only, as well as using linear mixed-effects models, and the results were largely robust to the different methods used. Adiposity could also potentially affect both dietary intake and blood SHBG concentrations. 2 We did observe substantially different SHBG levels comparing those with normal weight and those overweight or obese, suggesting possible effect modification by BMI, although the interaction terms were not significant when tested and corrected for multiple comparisons. Although we controlled for BMI in our analyses, we could not rule out the possibility of residual confounding because it is not a perfect measure of adiposity. Finally, although a large national sample of postmenopausal women participated in the WHI studies, resulting in a broader and more representative sample than those in studies based on samples of convenience, the findings presented herein can only be generalized to postmenopausal women, which is another limitation of the present study.
In conclusion, the present study found that dietary fiber intake, sugar intake, and GL or GI based on total and available carbohydrates had significant associations with serum SHBG concentrations, thus supporting a role for diet in influencing blood levels of SHBG, which is, in turn, an important protective factor probably associated with insulin resistance, T2D, CVD, and hormonedependent cancers. Further studies are needed to better elucidate the biological mechanisms underlying the associations between dietary carbohydrates and circulating SHBG concentrations, and mediation analyses with sufficient power are needed to evaluate whether these possible effects of dietary carbohydrates on SHBG extend to the ultimate cardiometabolic disease risk, which will contribute to a better understanding of the mechanisms of action underlying the effect of diets, particularly high-GL or -GL diets rich in refined carbohydrates. Table S1 . Results of sensitivity analysis with additional adjustment for total protein, total fruit and vegetable consumption, and baseline history of cardiovascular diseases and cancer. Table S2 . Results of sensitivity analysis restricting to nine studies using the chemiluminescent immunoassay method. Table S3 . Results of exploratory mediation analysis in AS238 diabetes case-control study.
